GYRE
Price
$9.13
Change
-$0.06 (-0.65%)
Updated
Apr 24, 02:18 PM (EDT)
Capitalization
861.49M
14 days until earnings call
PYXS
Price
$1.08
Change
-$0.00 (-0.00%)
Updated
Apr 24, 02:44 PM (EDT)
Capitalization
62.82M
15 days until earnings call
Ad is loading...

GYRE vs PYXS

Header iconGYRE vs PYXS Comparison
Open Charts GYRE vs PYXSBanner chart's image
Gyre Therapeutics
Price$9.13
Change-$0.06 (-0.65%)
Volume$100
Capitalization861.49M
Pyxis Oncology
Price$1.08
Change-$0.00 (-0.00%)
Volume$237
Capitalization62.82M
GYRE vs PYXS Comparison Chart
Loading...
GYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GYRE vs. PYXS commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GYRE is a StrongBuy and PYXS is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (GYRE: $9.19 vs. PYXS: $1.08)
Brand notoriety: GYRE and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GYRE: 60% vs. PYXS: 117%
Market capitalization -- GYRE: $861.49M vs. PYXS: $62.82M
GYRE [@Biotechnology] is valued at $861.49M. PYXS’s [@Biotechnology] market capitalization is $62.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GYRE’s FA Score shows that 0 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • GYRE’s FA Score: 0 green, 5 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, both GYRE and PYXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GYRE’s TA Score shows that 4 TA indicator(s) are bullish while PYXS’s TA Score has 4 bullish TA indicator(s).

  • GYRE’s TA Score: 4 bullish, 4 bearish.
  • PYXS’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, PYXS is a better buy in the short-term than GYRE.

Price Growth

GYRE (@Biotechnology) experienced а +15.74% price change this week, while PYXS (@Biotechnology) price change was +15.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.11%. For the same industry, the average monthly price growth was -6.02%, and the average quarterly price growth was -12.55%.

Reported Earning Dates

GYRE is expected to report earnings on Aug 19, 2025.

PYXS is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GYRE($861M) has a higher market cap than PYXS($62.8M). GYRE YTD gains are higher at: -24.050 vs. PYXS (-30.769). GYRE has higher annual earnings (EBITDA): 11.8M vs. PYXS (-64.04M). PYXS has more cash in the bank: 145M vs. GYRE (25.1M). GYRE has less debt than PYXS: GYRE (1.8M) vs PYXS (20.5M). GYRE has higher revenues than PYXS: GYRE (105M) vs PYXS (16.1M).
GYREPYXSGYRE / PYXS
Capitalization861M62.8M1,371%
EBITDA11.8M-64.04M-18%
Gain YTD-24.050-30.76978%
P/E Ratio183.80N/A-
Revenue105M16.1M652%
Total Cash25.1M145M17%
Total Debt1.8M20.5M9%
FUNDAMENTALS RATINGS
GYRE: Fundamental Ratings
GYRE
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
37
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GYREPYXS
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 24 days ago
82%
Bearish Trend 21 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
GYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMD90.394.13
+4.79%
Advanced Micro Devices
MREO2.560.06
+2.40%
Mereo BioPharma Group plc
PRO16.700.39
+2.39%
Pros Holdings
VANI1.040.02
+1.86%
Vivani Medical
FR47.100.75
+1.62%
First Industrial Realty Trust

GYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GYRE has been loosely correlated with SPRC. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if GYRE jumps, then SPRC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GYRE
1D Price
Change %
GYRE100%
+6.37%
SPRC - GYRE
38%
Loosely correlated
+4.52%
SRPT - GYRE
37%
Loosely correlated
+0.30%
BEAM - GYRE
36%
Loosely correlated
+3.87%
RYTM - GYRE
35%
Loosely correlated
+1.03%
PYXS - GYRE
35%
Loosely correlated
+5.88%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been closely correlated with KURA. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if PYXS jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
+5.88%
KURA - PYXS
67%
Closely correlated
+0.95%
BLRX - PYXS
45%
Loosely correlated
+2.41%
ABOS - PYXS
42%
Loosely correlated
+3.86%
BEAM - PYXS
41%
Loosely correlated
+3.87%
RXRX - PYXS
39%
Loosely correlated
-0.89%
More